Rui Chen

Rui Chen

Auto-generated profile, based on publicly available information

Rui Chen

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in Journal of Global Health
Verified
Journal Article
Open access
RCRui Chen
Rui Chen
JLJinxi Li
Jinxi Li
CWChan Wang
Chan Wang
PZPengfei Zhou
Pengfei Zhou
QSQihua Song
Qihua Song
Xiaoxv YinXiaoxv Yin
Xiaoxv Yin
Antimicrobial resistance (AMR) has become a global health problem [1]. It was associated with approximately 4.95 million deaths worldwide in 2019, of which 1.27 million were directly attributable [2]. As antibiotic consumption is an essential driver behind this phenomenon [3,4], promoting their rational use is a key strategy to control, which is one of the […]

8 September 2025 in BMJ Open Diabetes Research & Care
Verified
Journal Article
Open access
PDF file
RCRui Chen
Rui Chen
YZYing Zhou
Ying Zhou
MXMinzhi Xu
Minzhi Xu
YGYanhong Gong
Yanhong Gong
WXWenfei Xia
Wenfei Xia
Xiaoxv YinXiaoxv Yin
Xiaoxv Yin
Introduction: To examine the association of the number of controlled risk factors with the excess risk of severe metabolic dysfunction-associated steatotic liver disease (MASLD) and major adverse liver outcomes (MALO) among patients with type 2 diabetes. Research design and methods: In this cohort study, a total of 307,688 participants from the UK Biobank were included. Participants with baseline type 2 diabetes were categorized according to the number of risk factors within the guideline-recommended ranges (diet, smoking, drinking, exercise, sedentary behavior, body mass index, glycated hemoglobin, blood pressure, and low-density lipoprotein cholesterol). Results: During a median (IQR) of 12.5 (11.8–13.2) years of follow-up, 519 (3.9%) participants with type 2 diabetes and 2718 (0.9%) participants without diabetes developed severe MASLD. Patients with type 2 diabetes had an increased risk of severe MASLD compared with participants without diabetes (HR 3.93, 95% CI 3.56 to 4.33), but the excess risk decreased stepwise with an increasing number of risk factors on target (HR (95% CI) for zero to two controlled risk factors: 5.44 (4.09 to 7.25); three controlled risk factors: 4.47 (3.59 to 5.57); four controlled risk factors: 4.16 (3.49 to 4.96); five controlled risk factors: 3.91 (3.28 to 4.66); six controlled risk factors: 3.50 (2.80 to 4.38); seven to nine controlled risk factors: 2.61 (1.92 to 3.56)). Similar patterns were observed in the analysis of MALO. Conclusions: Patients with type 2 diabetes who had more controlled risk factors showed progressively lower excess risk of severe MASLD and MALO. Comprehensive interventions targeting multiple risk factors may be associated with reduced liver lesions in patients with type 2 diabetes.

3 October 2025 in Journal of Global Health
Verified
Journal Article
Open access
YZYing Zhou
Ying Zhou
RCRui Chen
Rui Chen
MXMinzhi Xu
Minzhi Xu
YGYanhong Gong
Yanhong Gong
CLChengbin Liu
Chengbin Liu
Xiaoxv YinXiaoxv Yin
Xiaoxv Yin
There is widespread consensus in the scientific community that obesity ranks as one of the leading public health challenges of the 21st century [1]. Globally, 43% of adults were overweight and 16% were living with obesity [2]. It is reported that two-thirds of excess mortality in obese people is attributable to cardiovascular disease (CVD) [3], […]